Citations: Regorafenib: an evidence-based review of its potential in patients with advanced liver cancer

104

Views

CrossRef citations to date

Altmetric

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Piyush Kumar Shukla, Mohammed Zakariah, Wesam Atef Hatamleh, Hussam Tarazi & Basant Tiwari. (2022) AI-DRIVEN Novel Approach for Liver Cancer Screening and Prediction Using Cascaded Fully Convolutional Neural Network. Journal of Healthcare Engineering 2022, pages 1-14.
Crossref

Swathi Veeroju, Baktybek Kojonazarov, Astrid Weiss, Hossein Ardeschir Ghofrani, Norbert Weissmann, Friedrich Grimminger, Werner Seeger, Tatyana Novoyatleva & Ralph Theo Schermuly. (2021) Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension. International Journal of Molecular Sciences 22:3, pages 1502.
Crossref

Gustavo Hideki Kawanami, Leopoldo Katsuda, Thiara Barcelos Rocha, Fabio da Silva Yamashiro, Leonardo Pelafsky, Xingshun Qi & Fernando Gomes Romeiro. (2021) How Much Time Should Be Waited and What Are the Main Findings to Evaluate the Hepatocellular Carcinoma Response to Regorafenib? A Real-Life Experience. Canadian Journal of Gastroenterology and Hepatology 2021, pages 1-5.
Crossref

Kyung-Min Han, Ri Jin Kang, Hyongjun Jeon, Hyun-ju Lee, Ji-Soo Lee, HyunHee Park, Seong Gak Jeon, Kyoungho Suk, Jinsoo Seo & Hyang-Sook Hoe. (2020) Regorafenib Regulates AD Pathology, Neuroinflammation, and Dendritic Spinogenesis in Cells and a Mouse Model of AD. Cells 9:7, pages 1655.
Crossref

Zhenghu Chen, Yanling Zhao, Yang Yu, Jonathan C. Pang, Sarah E. Woodfield, Ling Tao, Shan Guan, Huiyuan Zhang, Shayahati Bieerkehazhi, Yan Shi, Roma Patel, Sanjeev A. Vasudevan, Joanna S. Yi, Jodi A. Muscal, Guo-Tong Xu & Jianhua Yang. (2017) Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo . Oncotarget 8:61, pages 104090-104103.
Crossref

Ioannis A Ziogas & Georgios Tsoulfas. (2017) Evolving role of Sorafenib in the management of hepatocellular carcinoma. World Journal of Clinical Oncology 8:3, pages 203.
Crossref

Enrico Bronte, Giuseppe Bronte, Giuseppina Novo, Fabrizio Bronte, Maria Grazia Bavetta, Giuseppe Lo Re, Giuseppe Brancatelli, Viviana Bazan, Clara Natoli, Salvatore Novo & Antonio Russo. (2015) What links BRAF to the heart function? new insights from the cardiotoxicity of BRAF inhibitors in cancer treatment. Oncotarget 6:34, pages 35589-35601.
Crossref

Regorafenib: an evidence-based review of its potential in patients with advanced liver cancer

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Regorafenib: an evidence-based review of its potential in patients with advanced liver cancer

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date